Drug Side Effects
Search
PRE-ENGRAFTMENT IMMUNE REACTION
PRE-ENGRAFTMENT IMMUNE REACTION
was reported 80 times
PRE-ENGRAFTMENT IMMUNE REACTION is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Echinocandin Antifungal [EPC]
44
0.0054
1
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
43
0.0004
2
Anthracycline Topoisomerase Inhibitor [EPC]
1
0.0004
3
Alkylating Drug [EPC]
60
0.0002
4
Antimetabolite Immunosuppressant [EPC]
4
0.0002
5
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
16
0.0001
6
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
16
0.0001
7
CD30-directed Immunoconjugate [EPC]
1
0.0001
8
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0001
9
Lipid-based Polyene Antifungal [EPC]
1
0.0001
10
Corticosteroid [EPC]
51
0.0000
11
Azole Antifungal [EPC]
6
0.0000
12
BCL-2 Inhibitor [EPC]
2
0.0000
13
Glycopeptide Antibacterial [EPC]
2
0.0000
14
Topoisomerase Inhibitor [EPC]
2
0.0000
15
Polyene Antifungal [EPC]
1
0.0000
16
Nucleoside Analog Antiviral [EPC]
2
0.0000
17
Nucleoside Metabolic Inhibitor [EPC]
6
0.0000
18
Serotonin-3 Receptor Antagonist [EPC]
2
0.0000
19
Expectorant [EPC]
2
0.0000
20
Fluoroquinolone Antibacterial [EPC]
1
0.0000
21
Calcineurin Inhibitor Immunosuppressant [EPC]
1
0.0000
22
Leukocyte Growth Factor [EPC]
1
0.0000
23
Janus Kinase Inhibitor [EPC]
1
0.0000
24
Xanthine Oxidase Inhibitor [EPC]
1
0.0000
25
Benzodiazepine [EPC]
3
0.0000
26
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
27
Thalidomide Analog [EPC]
1
0.0000
28
Kinase Inhibitor [EPC]
1
0.0000